Forbes: Should you self-isolate for COVID-19 if you can’t smell?
UC specialist says your nose offers a clue about COVID-19
Loss of smell and taste is an unusual and relatively recently reported symptom of COVID-19 infection. Should patients with that as a new symptom, called anosmia, self-isolate?
A new study helps answer that question. Ahmad Sedaghat, associate professor of otolaryngology at the University of Cincinnati College of Medicine, and colleagues undertook a major literature review, reported in "Laryngoscope Investigative Otolaryngology."
Sedaghat, also a UC Health physician, reported findings based on his review of 19 studies which describe the sinus and nasal disorders reported in relation to the current coronavirus plaguing the nation. He concluded that patients with smell loss and no runny nose or stuffiness (that would be common with a cold) should self-isolate.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.